Clinical Trials Directory

Trials / Completed

CompletedNCT04263558

Echo: Optimizing a Group-based School Intervention for Children With Emotional Problems

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
1,364 (actual)
Sponsor
Regionsenter for barn og unges psykiske helse · Academic / Other
Sex
All
Age
8 Years – 12 Years
Healthy volunteers
Not accepted

Summary

The present study (Echo) will promote much needed research and innovation that optimize service provision in first line health services for the alarmingly high number of school children who suffer from clinical and subthreshold levels of anxiety and depression. The effect of different versions of an evidence-based intervention for this group of children will be tested using a cluster randomized design involving 40 schools across Norway. The aim is to create a framework that allows more evidence-based psychosocial interventions to be provided at a lower cost to society. Echo will provide knowledge about three main evidence gaps for children: (1) The effect of school-based preventive interventions on anxiety and depression; (2) The effect of feedback informed systems, and; (3) the effect and cost-effectiveness of digital health interventions using online sessions and virtual reality technology.

Conditions

Interventions

TypeNameDescription
BEHAVIORALEmotion childThe MFS will include an idiographic measure of personal aims, symptom burden, displayed on a visual data dashboard to guide further intervention. The EMOTION intervention for children 9 to 12 years with symptoms of anxiety and/or depression will be used in a standard/long version (16 sessions) and a short (8 sessions) but optimized version, using a partial web-based solution with virtual reality (VR)-technology for behavioral experiments and exposure (in short and long version). Parental involvement: Parental participation in a 5-session parent group (high involvement) versus sharing information with parents via a brochure (low Parental involvement).

Timeline

Start date
2020-02-13
Primary completion
2023-05-25
Completion
2023-05-25
First posted
2020-02-11
Last updated
2023-11-29

Locations

3 sites across 1 country: Norway

Source: ClinicalTrials.gov record NCT04263558. Inclusion in this directory is not an endorsement.